The CNS Summit is where top decision-makers gather to explore advancements in CNS clinical research. This year, Kevin Short, Director of Business Development, and Alyssa Boschen, PA-C, MMS, CPI, Regional Site Director, will represent our team. We have extensive experience with CNS indications, including Alzheimer’s disease, ADHD, major depressive disorder, schizophrenia, and more. Set up a meeting at the summit to discuss how we can advance CNS research together.